Literature DB >> 2514236

Immunocytochemical identification of HIV (p24) antigen in parotid lymphoid lesions.

J M Bruner1, K R Cleary, F B Smith, J G Batsakis.   

Abstract

Antibodies to specific human immunodeficiency virus (HIV) polypeptides are important laboratory markers of HIV infection. We have used an antibody to the major structural gag protein p24 of HIV-1 virus to immunochemically localize this capsid antigen in lymphoid cells from seven of eight patients at risk for HIV infection and who presented with parotid lymphadenopathy and lymphoepithelial cysts of the parotid gland. A clinicopathological assessment of these two manifestations as they relate to HIV infection is also presented.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2514236     DOI: 10.1017/s0022215100110990

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  5 in total

1.  Increased frequency of HLA-DR11 in pediatric human immunodeficiency virus-associated parotid gland enlargement.

Authors:  S J Schuval; M E O'Reilly; V R Bonagura
Journal:  Clin Diagn Lab Immunol       Date:  1997-05

2.  Effects of long-term use of HAART on oral health status of HIV-infected subjects.

Authors:  Wipawee Nittayananta; Sineepat Talungchit; Sutep Jaruratanasirikul; Kachornsakdi Silpapojakul; Panthip Chayakul; Ampaipith Nilmanat; Nannapat Pruphetkaew
Journal:  J Oral Pathol Med       Date:  2010-02-22       Impact factor: 4.253

3.  HIV-related parotid lymphoepithelial cysts. Immunohistochemistry and 3-D reconstruction of surgical and autopsy material with special reference to formal pathogenesis.

Authors:  S Ihrler; C Zietz; A Riederer; J Diebold; U Löhrs
Journal:  Virchows Arch       Date:  1996-10       Impact factor: 4.064

4.  Effect of HAART on salivary gland function in the Women's Interagency HIV Study (WIHS).

Authors:  M Navazesh; R Mulligan; R Karim; W J Mack; S Ram; H Seirawan; J Greenspan; D Greenspan; J Phelan; M Alves
Journal:  Oral Dis       Date:  2008-11-11       Impact factor: 3.511

5.  Differences in Salivary Flow Level, Xerostomia, and Flavor Alteration in Mexican HIV Patients Who Did or Did Not Receive Antiretroviral Therapy.

Authors:  Sandra López-Verdín; Jaime Andrade-Villanueva; Ana Lourdes Zamora-Perez; Ronell Bologna-Molina; José Justino Cervantes-Cabrera; Nelly Molina-Frechero
Journal:  AIDS Res Treat       Date:  2013-12-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.